Advocacy intelligence hub — real-time data for patient organizations
Longboard Pharmaceuticals — PHASE3
Weill Medical College of Cornell University — EARLY_PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all KCNQ2-related developmental and epileptic encephalopathy news →
View all KCNQ2-related developmental and epileptic encephalopathy specialists →